| FXAIX | SDYYX | FXAIX / SDYYX | |
| Total Expense Ratio | 0.01 | 0.50 | 3% |
| Annual Report Gross Expense Ratio | 0.01 | 0.93 | 2% |
| Fund Existence | 15 years | 11 years | - |
| Gain YTD | 10.128 | 8.870 | 114% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 833B | 837M | 99,522% |
| Annual Yield % from dividends | 1.06 | 1.60 | 66% |
| Returns for 1 year | 19.55 | 0.01 | 191,123% |
| Returns for 3 years | 70.29 | 18.78 | 374% |
| Returns for 5 years | 82.96 | 7.07 | 1,173% |
| Returns for 10 years | 284.67 | 122.13 | 233% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SLGCX | 1.97 | 0.01 | +0.51% |
| Saratoga Large Capitalization Growth C | |||
| BERIX | 14.38 | -0.01 | -0.07% |
| Carillon Chartwell Real Income I | |||
| PCCGX | 12.40 | -0.03 | -0.24% |
| Victory Pioneer Mid Cap Value C | |||
| ERSMX | 29.37 | -0.20 | -0.68% |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| FBTCX | 34.49 | -0.83 | -2.35% |
| Fidelity Advisor Biotechnology C | |||